Chardan Capital Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Chardan Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Chardan Capital. Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Europe Australia Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActionsEYPTEyePoint Pharmaceuticals5/18/2023Target Raised byChardan Capital$21.00 -> $22.00LowFBRXForte Biosciences5/15/2023Reiterated byChardan CapitalAnalyst K. NakaeNeutralLowKITTNauticus Robotics5/12/2023Downgraded byChardan CapitalBuy -> Neutral $2.50LowTNYATenaya Therapeutics5/11/2023Target Lowered byChardan Capital$24.00 -> $23.00LowVLNValens Semiconductor5/11/2023Target Lowered byChardan CapitalBuy$13.00 -> $12.00LowQUREuniQure5/10/2023Target Lowered byChardan Capital$60.00 -> $56.00LowOCGNOcugen5/7/2023Target Raised byChardan CapitalAnalyst D. Gataulin$3.50 -> $4.00LowRCKTRocket Pharmaceuticals5/5/2023Target Lowered byChardan Capital$63.00 -> $61.00LowRGNXREGENXBIO5/4/2023Target Lowered byChardan Capital$61.00 -> $55.00LowMCRBSeres Therapeutics4/28/2023Target Lowered byChardan Capital$12.00 -> $10.00LowWBXWallbox4/18/2023Reiterated byChardan CapitalBuy $12.00LowIMRXImmuneering4/18/2023Target Raised byChardan CapitalBuy$18.00 -> $22.00LowOCGNOcugen4/14/2023Reiterated byChardan CapitalAnalyst D. GataulinBuy $3.50LowCLSKCleanSpark4/17/2023Reiterated byChardan CapitalBuy $5.00LowNVVENuvve4/3/2023Reiterated byChardan CapitalBuy $2.50LowMARAMarathon Digital4/3/2023Reiterated byChardan CapitalBuy $15.00LowBTTXBetter Therapeutics3/31/2023Target Lowered byChardan CapitalBuy$14.00 -> $9.00LowCOYACoya Therapeutics3/30/2023Reiterated byChardan CapitalAnalyst K. NakaeBuy $9.00LowRNAAvidity Biosciences3/31/2023Reiterated byChardan CapitalBuy $27.00N/AFEMYFemasys3/30/2023Target Lowered byChardan CapitalBuy$12.00 -> $10.00LowTSHATaysha Gene Therapies3/29/2023Target Lowered byChardan CapitalBuy$6.00 -> $5.00LowSYBXSynlogic3/29/2023Target Lowered byChardan CapitalBuy$7.00 -> $5.50LowMARAMarathon Digital3/28/2023Target Lowered byChardan CapitalBuy$17.00 -> $15.00LowBMTXBM Technologies3/29/2023Reiterated byChardan CapitalBuy $13.00LowAMTIApplied Molecular Transport3/28/2023Downgraded byChardan CapitalBuy -> NeutralLowNVVENuvve3/27/2023Target Lowered byChardan CapitalBuy$11.00 -> $2.50LowGANXGain Therapeutics3/27/2023Target Raised byChardan Capital$4.00 -> $5.75LowOUSTOuster3/24/2023Downgraded byChardan CapitalBuy -> Neutral $10.00LowSNTISenti Biosciences3/23/2023Target Lowered byChardan CapitalBuy$8.00 -> $7.00LowIMTXImmatics3/23/2023Target Lowered byChardan CapitalBuy$28.00 -> $25.00LowCOYACoya Therapeutics3/22/2023Reiterated byChardan CapitalAnalyst K. NakaeBuy $9.00LowANIXAnixa Biosciences3/22/2023Reiterated byChardan CapitalAnalyst M. BarcusBuy$8.00 -> $9.00LowCABACabaletta Bio3/22/2023Reiterated byChardan CapitalBuy $12.00LowIPSCCentury Therapeutics3/22/2023Reiterated byChardan CapitalAnalyst G. LivshitsBuy $19.00LowIMNMImmunome3/16/2023Target Lowered byChardan CapitalBuy$9.00 -> $8.00LowCRGOFreightos3/16/2023Target Lowered byChardan CapitalBuy$13.00 -> $11.00LowMGTXMeiraGTx3/16/2023Target Lowered byChardan CapitalBuy$47.00 -> $41.00LowSLNSilence Therapeutics3/16/2023Target Lowered byChardan CapitalBuy$29.00 -> $26.00LowPRVBProvention Bio3/13/2023Target Lowered byChardan CapitalBuy$30.00 -> $25.00LowNRGVEnergy Vault3/9/2023Target Lowered byChardan CapitalBuy$13.00 -> $7.00LowTNYATenaya Therapeutics3/9/2023Target Lowered byChardan CapitalBuy$28.00 -> $24.00LowMCRBSeres Therapeutics3/8/2023Reiterated byChardan CapitalBuy $12.00LowACHLAchilles Therapeutics3/8/2023Target Lowered byChardan Capital$17.00 -> $12.00LowIMRXImmuneering3/7/2023Reiterated byChardan CapitalBuy $18.00N/AAMTIApplied Molecular Transport3/6/2023Reiterated byChardan CapitalBuyLowEYPTEyePoint Pharmaceuticals3/3/2023Reiterated byChardan CapitalBuy $21.00LowGWHESS Tech3/3/2023Target Lowered byChardan CapitalNeutral$4.50 -> $1.80LowVLNValens Semiconductor3/3/2023Reiterated byChardan CapitalBuy $13.00LowABUSArbutus Biopharma3/3/2023Reiterated byChardan CapitalBuy $6.00LowDYNDyne Therapeutics3/3/2023Target Raised byChardan CapitalBuy$17.00 -> $20.00LowRGNXREGENXBIO3/2/2023Reiterated byChardan CapitalBuy $61.00LowIOVAIovance Biotherapeutics3/1/2023Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $29.00LowMESOMesoblast3/1/2023Reiterated byChardan CapitalSell $2.50LowRNAAvidity Biosciences3/1/2023Reiterated byChardan CapitalBuy $27.00LowOCGNOcugen3/1/2023Upgraded byChardan CapitalAnalyst D. GataulinNeutral -> Buy $3.50LowRCKTRocket Pharmaceuticals3/1/2023Target Lowered byChardan CapitalBuy$65.00 -> $63.00LowKRYSKrystal Biotech2/28/2023Reiterated byChardan CapitalBuy $133.00LowQUREuniQure2/28/2023Reiterated byChardan CapitalBuy $60.00LowLICYLi-Cycle2/28/2023Reiterated byChardan CapitalBuy $10.00LowCRGOFreightos2/28/2023Reiterated byChardan CapitalBuyLowNTLAIntellia Therapeutics2/24/2023Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$129.00 -> $111.00LowWBXWallbox2/24/2023Target Lowered byChardan CapitalBuy$13.00 -> $12.00LowALNYAlnylam Pharmaceuticals2/24/2023Reiterated byChardan CapitalBuy $250.00LowEDITEditas Medicine2/23/2023Target Lowered byChardan CapitalBuy$35.00 -> $22.00LowPETWag! Group2/22/2023Target Raised byChardan CapitalBuy$5.00 -> $8.00LowCRSPCRISPR Therapeutics2/22/2023Target Lowered byChardan CapitalBuy$153.00 -> $123.00LowFREQFrequency Therapeutics2/15/2023Downgraded byChardan CapitalAnalyst D. GataulinBuy -> NeutralLowPLBYPLBY Group2/13/2023Reiterated byChardan CapitalBuy $5.00LowDFLIDragonfly Energy2/10/2023Target Lowered byChardan CapitalBuy$15.00 -> $10.00LowARWRArrowhead Pharmaceuticals2/10/2023Reiterated byChardan CapitalBuy $60.00LowPPBTPurple Biotech2/9/2023Reiterated byChardan CapitalAnalyst M. BarcusBuy $11.00LowBMTXBM Technologies2/7/2023Target Lowered byChardan CapitalBuy$21.00 -> $13.00LowOBIOOrchestra BioMed2/7/2023Initiated byChardan CapitalAnalyst K. NakaeBuy $20.00LowIMVTImmunovant2/5/2023Target Raised byChardan CapitalBuy$19.00 -> $21.00LowTSHATaysha Gene Therapies2/1/2023Target Lowered byChardan CapitalBuy$16.00 -> $6.00LowLICYLi-Cycle1/31/2023Target Lowered byChardan CapitalBuy$13.00 -> $10.00LowSNTISenti Biosciences1/27/2023Target Lowered byChardan CapitalBuy$12.00 -> $8.00LowCOYACoya Therapeutics1/26/2023Initiated byChardan CapitalAnalyst K. NakaeBuy $9.00N/AMRNAModerna1/18/2023Target Raised byChardan CapitalAnalyst Y. LivshitsNeutral$191.00 -> $208.00LowARWRArrowhead Pharmaceuticals1/10/2023Target Lowered byChardan Capital$82.00 -> $60.00LowGIACGesher I Acquisition12/27/2022Initiated byChardan CapitalBuy $13.00LowIPSCCentury Therapeutics12/27/2022Initiated byChardan CapitalAnalyst G. LivshitsBuy $19.00LowANIXAnixa Biosciences12/23/2022Initiated byChardan CapitalBuy $8.00LowXLOXilio Therapeutics12/21/2022Initiated byChardan CapitalAnalyst M. BarcusBuy $7.00LowCLSKCleanSpark12/15/2022Target Lowered byChardan CapitalBuy$6.00 -> $5.00LowPASGPassage Bio12/15/2022Target Lowered byChardan CapitalBuy$18.00 -> $11.00LowMRNAModerna12/14/2022Downgraded byChardan CapitalAnalyst Y. LivshitsBuy -> Neutral$186.00 -> $191.00LowGANXGain Therapeutics12/9/2022Initiated byChardan CapitalBuy $4.00LowFREQFrequency Therapeutics12/8/2022Initiated byChardan CapitalAnalyst D. GataulinBuy $7.00LowACHLAchilles Therapeutics12/6/2022Target Lowered byChardan CapitalBuy$20.00 -> $17.00LowAMTIApplied Molecular Transport12/2/2022Initiated byChardan CapitalBuyLowSQZSQZ Biotechnologies12/1/2022Target Lowered byChardan CapitalBuy$16.00 -> $4.00LowPRVBProvention Bio11/18/2022Target Raised byChardan CapitalBuy$24.00 -> $30.00LowIOVAIovance Biotherapeutics11/18/2022Target Lowered byChardan CapitalBuy$30.00 -> $29.00LowDFLIDragonfly Energy11/18/2022Initiated byChardan CapitalBuy $15.00LowEDITEditas Medicine11/17/2022Target Lowered byChardan CapitalBuy$43.00 -> $35.00LowSLNSilence Therapeutics11/17/2022Target Lowered byChardan CapitalBuy$33.00 -> $29.00LowFIXXHomology Medicines11/17/2022Target Lowered byChardan CapitalAnalyst M. BarcusBuy -> Buy$10.00 -> $8.00LowVINCVincerx Pharma11/16/2022Target Lowered byChardan CapitalBuy$4.00 -> $3.00LowEVLOEvelo Biosciences11/16/2022Downgraded byChardan CapitalAnalyst K. NakaeBuy -> Neutral $2.50LowBTTXBetter Therapeutics11/15/2022Target Lowered byChardan CapitalBuy$17.00 -> $14.00LowPDSBPDS Biotechnology11/14/2022Target Raised byChardan CapitalBuy$15.00 -> $16.00LowNTLAIntellia Therapeutics11/14/2022Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$121.00 -> $129.00LowCABACabaletta Bio11/11/2022Target Lowered byChardan CapitalBuy$13.00 -> $12.00LowADVMAdverum Biotechnologies11/11/2022Target Lowered byChardan CapitalNeutral$2.50 -> $2.00LowTNYATenaya Therapeutics11/11/2022Target Lowered byChardan CapitalBuy$30.00 -> $28.00LowSYBXSynlogic11/11/2022Target Lowered byChardan CapitalAnalyst Keay NakaeBuy$9.00 -> $7.00LowFEMYFemasys11/11/2022Target Lowered byChardan CapitalBuy$15.00 -> $12.00LowSQZSQZ Biotechnologies11/10/2022Target Lowered byChardan CapitalAnalyst G. LivshitsBuy$17.00 -> $16.00LowTSHATaysha Gene Therapies11/9/2022Target Lowered byChardan CapitalBuy$32.00 -> $16.00LowEBSEmergent BioSolutions11/9/2022Target Lowered byChardan CapitalBuy$65.00 -> $55.00LowVTRSViatris11/7/2022Downgraded byChardan CapitalBuy -> NeutralN/AKRYSKrystal Biotech11/7/2022Target Raised byChardan CapitalBuy$130.00 -> $133.00LowIMVTImmunovant11/7/2022Target Raised byChardan CapitalBuy$12.00 -> $19.00LowMRNAModerna11/7/2022Target Lowered byChardan CapitalBuy$188.00 -> $186.00LowGWHESS Tech11/4/2022Target Lowered byChardan CapitalNeutral$5.00 -> $4.50LowRGNXREGENXBIO11/4/2022Target Lowered byChardan CapitalBuy$70.00 -> $61.00LowPRVBProvention Bio11/4/2022Target Raised byChardan CapitalBuy$21.00 -> $24.00N/ANTLAIntellia Therapeutics11/3/2022Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$146.00 -> $121.00LowEDITEditas Medicine11/2/2022Target Lowered byChardan CapitalBuy$60.00 -> $43.00LowAXLAAxcella Health11/2/2022Target Lowered byChardan CapitalAnalyst Keay NakaeBuy$7.00 -> $5.00LowCORZCore Scientific10/28/2022Downgraded byChardan CapitalBuy -> NeutralLowCLSKCleanSpark10/28/2022Target Lowered byChardan CapitalBuy$9.00 -> $6.00LowPLBYPLBY Group10/21/2022Target Lowered byChardan CapitalBuy$9.00 -> $5.00LowKITTNauticus Robotics10/10/2022Initiated byChardan CapitalBuy $11.00LowRCKTRocket Pharmaceuticals9/30/2022Target Raised byChardan CapitalBuy$62.00 -> $65.00LowPETWag! Group9/30/2022Initiated byChardan CapitalBuy $5.00LowIMVTImmunovant9/29/2022Target Lowered byChardan CapitalAnalyst M. BarcusBuy$14.00 -> $12.00LowRNAAvidity Biosciences9/27/2022Target Lowered byChardan CapitalAnalyst K. NakaeBuy$29.00 -> $27.00LowOMGAOmega Therapeutics9/23/2022Initiated byChardan CapitalBuy $12.00LowSNTISenti Biosciences9/22/2022Initiated byChardan CapitalBuy $12.00LowNTLAIntellia Therapeutics9/16/2022Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $146.00LowLICYLi-Cycle9/15/2022Target Lowered byChardan CapitalBuy$18.00 -> $13.00LowOTLKOutlook Therapeutics9/13/2022Initiated byChardan CapitalBuyLowPPBTPurple Biotech9/8/2022Initiated byChardan CapitalAnalyst M. BarcusBuy $11.00LowFBRXForte Biosciences8/17/2022Downgraded byChardan CapitalAnalyst K. NakaeBuy -> NeutralLowFIXXHomology Medicines8/16/2022Target Lowered byChardan CapitalAnalyst M. BarcusBuy -> Buy$14.00 -> $10.00LowEVLOEvelo Biosciences8/15/2022Target Lowered byChardan CapitalBuy$12.00 -> $5.00LowGWHESS Tech8/15/2022Target Raised byChardan CapitalNeutral$3.50 -> $5.00LowCLSKCleanSpark8/15/2022Target Raised byChardan CapitalBuy$7.00 -> $9.00LowADVMAdverum Biotechnologies8/12/2022Target Lowered byChardan CapitalAnalyst D. GataulinNeutral$3.00 -> $2.50LowMGTXMeiraGTx8/12/2022Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$46.00 -> $47.00LowTSHATaysha Gene Therapies8/12/2022Target Lowered byChardan CapitalBuy$34.00 -> $32.00LowSLDBSolid Biosciences8/12/2022Target Lowered byChardan CapitalBuy$105.00 -> $90.00LowCABACabaletta Bio8/12/2022Target Lowered byChardan CapitalBuy$17.00 -> $13.00LowPRQRProQR Therapeutics8/12/2022Downgraded byChardan CapitalAnalyst K. NakaeBuy -> NeutralLowSABSSAB Biotherapeutics8/11/2022Target Lowered byChardan CapitalBuy$7.00 -> $3.00LowTNYATenaya Therapeutics8/11/2022Target Lowered byChardan CapitalBuy$31.00 -> $30.00LowIMTXImmatics8/10/2022Target Lowered byChardan CapitalBuy$30.00 -> $28.00LowKODKodiak Sciences8/10/2022Target Lowered byChardan CapitalAnalyst D. GataulinBuy$19.00 -> $18.00LowPLBYPLBY Group8/10/2022Target Lowered byChardan CapitalBuy$13.00 -> $9.00LowQUREuniQure8/9/2022Target Lowered byChardan CapitalAnalyst M. BarcusBuy$65.00 -> $60.00LowCRSPCRISPR Therapeutics8/9/2022Target Lowered byChardan CapitalBuy$164.00 -> $154.00LowKRYSKrystal Biotech8/9/2022Target Lowered byChardan CapitalBuy$137.00 -> $130.00LowNVVENuvve8/8/2022Target Lowered byChardan CapitalBuy$24.00 -> $11.00LowARWRArrowhead Pharmaceuticals8/5/2022Target Raised byChardan Capital$80.00 -> $82.00LowIOVAIovance Biotherapeutics8/5/2022Target Lowered byChardan Capital$31.00 -> $30.00LowPASGPassage Bio8/5/2022Target Lowered byChardan Capital$34.00 -> $18.00LowPRVBProvention Bio8/5/2022Target Lowered byChardan CapitalBuy$22.50 -> $21.00LowNTLAIntellia Therapeutics8/5/2022Target Lowered byChardan CapitalBuy$172.00 -> $146.00LowMCRBSeres Therapeutics8/4/2022Target Lowered byChardan Capital$16.00 -> $12.00LowALNYAlnylam Pharmaceuticals8/4/2022Target Raised byChardan CapitalAnalyst Keay NakaeBuy$200.00 -> $250.00LowPLBYPLBY Group8/3/2022Target Lowered byChardan CapitalBuy$21.00 -> $13.00LowVBLTVascular Biogenics7/20/2022Downgraded byChardan CapitalAnalyst M. BarcusBuy -> NeutralLowDYNDyne Therapeutics7/20/2022Initiated byChardan CapitalBuy $17.00LowRNAAvidity Biosciences7/20/2022Initiated byChardan CapitalAnalyst K. NakaeBuy $29.00LowIMRXImmuneering7/8/2022Initiated byChardan CapitalBuy $18.00N/AEYPTEyePoint Pharmaceuticals7/7/2022Initiated byChardan CapitalAnalyst D. GataulinBuy $21.00N/ASLDPSolid Power6/29/2022Initiated byChardan CapitalBuy $8.00LowNRGVEnergy Vault6/29/2022Initiated byChardan CapitalBuy $13.00LowGWHESS Tech6/29/2022Initiated byChardan CapitalNeutral $3.50LowCRSPCRISPR Therapeutics6/22/2022Target Lowered byChardan CapitalBuy$168.00 -> $164.00LowSYBXSynlogic6/10/2022Reiterated byChardan CapitalAnalyst Keay NakaeBuy $9.00HighVINCVincerx Pharma6/7/2022Target Lowered byChardan CapitalAnalyst M. BarcusBuy$11.00 -> $4.00HighMESOMesoblast6/3/2022Target Lowered byChardan CapitalSell$6.50 -> $2.50LowMARAMarathon Digital6/3/2022Initiated byChardan CapitalBuy $19.00LowCORZCore Scientific6/3/2022Initiated byChardan CapitalBuy $8.00HighCLSKCleanSpark6/3/2022Initiated byChardan CapitalBuy $12.00LowIOVAIovance Biotherapeutics5/27/2022Target Lowered byChardan CapitalBuy$44.00 -> $31.00HighSQZSQZ Biotechnologies5/25/2022Initiated byChardan CapitalAnalyst G. LivshitsBuy $17.00HighRCKTRocket Pharmaceuticals5/19/2022Target Raised byChardan CapitalBuy$60.00 -> $62.00HighTSHATaysha Gene Therapies5/17/2022Target Lowered byChardan Capital$37.00 -> $34.00MediumFIXXHomology Medicines5/17/2022Target Lowered byChardan CapitalAnalyst M. BarcusNA $14.00HighBTTXBetter Therapeutics5/16/2022Target Lowered byChardan CapitalAnalyst K. NakaeNA $15.00LowMGTXMeiraGTx5/13/2022Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $46.00MediumSABSSAB Biotherapeutics5/13/2022Target Lowered byChardan CapitalAnalyst K. Nakae$10.00 -> $7.00HighIMNMImmunome5/13/2022Target Lowered byChardan Capital$16.00 -> $9.00HighCRSPCRISPR Therapeutics5/10/2022Target Lowered byChardan Capital$171.00 -> $168.00HighOCGNOcugen5/9/2022Target Lowered byChardan CapitalAnalyst D. GataulinNeutral -> Neutral$4.00 -> $3.50HighAXLAAxcella Health5/9/2022Target Lowered byChardan CapitalBuy$12.00 -> $7.00HighEBSEmergent BioSolutions4/29/2022Target Lowered byChardan Capital$75.00 -> $65.00HighSLDBSolid Biosciences4/28/2022Target Lowered byChardan Capital$255.00 -> $105.00HighVBLTVascular Biogenics4/28/2022Initiated byChardan CapitalAnalyst M. BarcusBuy $5.00HighPRQRProQR Therapeutics4/14/2022Target Lowered byChardan CapitalBuy$8.00 -> $2.50HighRGNXREGENXBIO4/11/2022Reiterated byChardan CapitalAnalyst D. GataulinBuyMediumKODKodiak Sciences4/11/2022Reiterated byChardan CapitalAnalyst D. GataulinBuyHighADVMAdverum Biotechnologies4/11/2022Reiterated byChardan CapitalAnalyst D. GataulinNeutralMediumOCGNOcugen4/11/2022Reiterated byChardan CapitalAnalyst D. GataulinNeutralHighSABSSAB Biotherapeutics4/1/2022Target Lowered byChardan CapitalAnalyst K. NakaeBuy$17.00 -> $10.00LowVINCVincerx Pharma3/29/2022Reiterated byChardan CapitalAnalyst Y. LivshitsBuyLowIMVTImmunovant3/29/2022Reiterated byChardan CapitalAnalyst Y. LivshitsBuyMediumFIXXHomology Medicines3/29/2022Reiterated byChardan CapitalAnalyst Y. LivshitsBuyHighTSHATaysha Gene Therapies3/31/2022Target Lowered byChardan Capital$60.00 -> $37.00HighWBXWallbox3/31/2022Initiated byChardan CapitalBuy $19.00LowOUSTOuster3/31/2022Initiated byChardan CapitalBuy $70.00HighSLNSilence Therapeutics3/31/2022Initiated byChardan CapitalAnalyst K. NakaeBuy $33.00LowQUREuniQure3/30/2022Target Lowered byChardan CapitalAnalyst M. Barcus$95.00 -> $65.00LowVINCVincerx Pharma3/30/2022Target Lowered byChardan CapitalAnalyst M. Barcus$30.00 -> $14.00LowIMVTImmunovant3/30/2022Target Lowered byChardan CapitalAnalyst M. Barcus$20.00 -> $14.00HighIMNMImmunome3/30/2022Target Lowered byChardan Capital$21.00 -> $16.00HighRGNXREGENXBIO3/29/2022Target Lowered byChardan Capital$90.00 -> $76.00HighOCGNOcugen3/29/2022Target Lowered byChardan Capital$4.50 -> $4.00HighKODKodiak Sciences3/29/2022Target Lowered byChardan Capital$82.50 -> $19.00HighVINCVincerx Pharma3/22/2022Reiterated byChardan CapitalAnalyst M. BarcusBuyMediumQUREuniQure3/22/2022Reiterated byChardan CapitalAnalyst M. BarcusBuyMediumIMVTImmunovant3/22/2022Reiterated byChardan CapitalAnalyst M. BarcusBuyLowFIXXHomology Medicines3/22/2022Reiterated byChardan CapitalAnalyst M. BarcusBuyLowFEMYFemasys3/25/2022Target Lowered byChardan CapitalBuy$25.00 -> $18.00MediumBTTXBetter Therapeutics3/16/2022Target Raised byChardan CapitalAnalyst K. NakaeBuy$17.00 -> $18.00HighPASGPassage Bio3/11/2022Target Lowered byChardan Capital$43.00 -> $34.00LowVYGRVoyager Therapeutics3/9/2022Target Raised byChardan Capital$4.00 -> $6.00HighABUSArbutus Biopharma3/4/2022Target Raised byChardan CapitalBuy$5.50 -> $6.00HighPLBYPLBY Group3/2/2022Target Lowered byChardan CapitalBuy$49.00 -> $39.00HighNTLAIntellia Therapeutics3/1/2022Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$177.00 -> $172.00HighEDITEditas Medicine2/25/2022Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$75.00 -> $60.00HighIOVAIovance Biotherapeutics2/25/2022Target Lowered byChardan CapitalBuy$50.00 -> $45.00HighFIXXHomology Medicines2/22/2022Target Lowered byChardan CapitalBuy$25.00 -> $15.00HighPRQRProQR Therapeutics2/14/2022Target Lowered byChardan CapitalAnalyst Keay NakaeBuy$18.00 -> $8.00HighALNYAlnylam Pharmaceuticals2/11/2022Reiterated byChardan CapitalAnalyst Keay NakaeBuy $200.00MediumTNYATenaya Therapeutics1/17/2022Reiterated byChardan CapitalAnalyst Y. LivshitsBuyLowLICYLi-Cycle1/13/2022Target Raised byChardan CapitalBuy$17.00 -> $18.00MediumIMVTImmunovant1/5/2022Target Lowered byChardan CapitalAnalyst M. BarcusBuy -> Buy$22.00 -> $20.00HighNVVENuvve12/21/2021Initiated byChardan CapitalBuy $24.00HighVINCVincerx Pharma12/17/2021Reiterated byChardan CapitalAnalyst Geulah LivshitsBuy $30.00MediumRCKTRocket Pharmaceuticals12/15/2021Target Raised byChardan CapitalAnalyst Geulah LivshitsBuy$56.00 -> $60.00HighABUSArbutus Biopharma12/2/2021Target Raised byChardan CapitalBuy$5.00 -> $5.50HighBTTXBetter Therapeutics11/24/2021Initiated byChardan CapitalAnalyst K. NakaeBuy $17.00HighBMTXBM Technologies11/23/2021Initiated byChardan CapitalBuy $21.00HighLTRYLottery.com11/23/2021Initiated byChardan CapitalBuy $14.00MediumVLNValens Semiconductor11/23/2021Initiated byChardan CapitalBuy $13.00HighLICYLi-Cycle11/23/2021Initiated byChardan CapitalBuy $17.00HighPLBYPLBY Group11/23/2021Initiated byChardan CapitalBuy $49.00LowAXLAAxcella Health11/16/2021Target Raised byChardan CapitalAnalyst Keay NakaeBuy$10.00 -> $12.00LowFIXXHomology Medicines11/16/2021Target Lowered byChardan CapitalAnalyst M. BarcusBuy$30.00 -> $25.00HighEBSEmergent BioSolutions11/10/2021Target Lowered byChardan CapitalBuy$92.00 -> $75.00LowSABSSAB Biotherapeutics11/5/2021Initiated byChardan CapitalAnalyst K. NakaeBuy $17.00LowABUSArbutus Biopharma11/4/2021Reiterated byChardan CapitalBuyMediumRGNXREGENXBIO11/3/2021Target Lowered byChardan CapitalAnalyst Geulah LivshitsBuy$100.00 -> $90.00HighVYGRVoyager Therapeutics11/2/2021Target Lowered byChardan CapitalAnalyst Y. LivshitsNeutral$5.50 -> $4.00LowEVLOEvelo Biosciences11/1/2021Upgraded byChardan CapitalAnalyst Keay NakaeNeutral -> Buy $12.00Medium MarketBeat Community Rating for Chardan CapitalCommunity Ranking: 2.7 out of 5 (2.7 of 5 stars)Outperform Votes: 20,204 (Vote Outperform)Underperform Votes: 16,831 (Vote Underperform)Total Votes: 37,035MarketBeat's community ratings are surveys of what our community members think about Chardan Capital and other research firms. Vote "Outperform" if you believe Chardan Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Chardan Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings European Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.